This most up-to-date twist in the Lykos Therapeutics saga threatens A significant overhaul of the business’s approach and route, with Musk ally and billionaire investor Antonio Gracias showing to would like to just take the corporation again toward its nonprofit drug growth roots and a more Doblinite philosophy.Also to be good, it’s not like ri